Sunbird Bio
PrivateLast Round
Early Funding
Oct 16, 2024
Total Funding Raised
$36M
Company Overview
Sunbird Bio is a biotechnology company that develops proprietary blood-based diagnostic tests to enable earlier, more accurate diagnosis and treatment of neurological disorders and early-stage cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sunbird Bio Comparables
Compare Sunbird Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| C2N Diagnostics | 82% | |
| ADmit Therapeutics | 79% | |
| ALZpath, Inc. | 79% |
Sunbird Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Oct 16, 2024 | ||||
| M&A | Aug 9, 2023 | ||||
| VC Round | May 12, 2023 | ||||
| Series A | Oct 11, 2018 |
Sunbird Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GreatPoint Ventures | Series A |
| S32 | Early Funding |
| ARCH Venture Partners | Series A |
| ClavystBio | Early Funding |
| EDBI | Early Funding |
| Yonghua Capital | Series A |
| Rivas Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 8, 2025
Richard Batrla appointed as the new Chief Medical Officer.
- Oct 16, 2024
$14M raised with EDBI and Eli Lilly leading.
Sunbird Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Sunbird Bio's valuation, stock price, and market status.
Is Sunbird Bio a public or private company?
Sunbird Bio is a private company.
What is the current stock price of Sunbird Bio?
Sunbird Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Sunbird Bio worth (valuation)?
Valuation information for Sunbird Bio is not publicly available.
Can I buy Sunbird Bio stock?
Sunbird Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Sunbird Bio's last funding round?
Sunbird Bio's most recent funding round was Series A on October 16, 2024.
Who are the main investors in Sunbird Bio?
Key investors in Sunbird Bio include EDBI.
Will Sunbird Bio IPO soon?
No public IPO plans have been announced for Sunbird Bio.
How can I track Sunbird Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sunbird Bio's secondary market activity and sign up for updates.